Skip to Content

NAPROXEN 50MG/ML ORAL SUSPENSION

Active substance(s): NAPROXEN

View full screen / Print PDF » Download PDF ⇩
Transcript
Mock up; BPZ Naproxen; size: 860 x 210 mm; colour: black; font: Helvetica; fontsize: 11Pt; Id.-Nr.: 1540100411G02

Package leaflet: Information for the user

Naproxen 50mg/m
Oral Suspension
Naproxen
For children from 2 years of age and adults
Read all of this leaflet carefully before you start
taking this medicine because it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or
pharmacist.
- This medicine has been prescribed for you only. Do
not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
What is in this leaflet
1. What Naproxen is and what it is used for
2. What you need to know before you take Naproxen
3. How to take Naproxen
4. Possible side effects
5. How to store Naproxen
6. Contents of the pack and other information

1. What Naproxen is and what it is used for
Naproxen Oral Suspension contains a medicine called
naproxen. This is a ‘Non-Steroidal Anti-Inflammatory
Drug’ or NSAID.
Naproxen is used in adults for the symptomatic
treatment of:
- pain and inflammation in:
• rheumatoid arthritis, ankylosing spondylitis (pain
and stiffness in the neck and back), acute attacks of
osteoarthrosis and spondylarthrosis
• acute gout

1540100411G02.indd 1

• inflammatory rheumatic diseases of soft tissues
• painful swelling or inflammation after
musculoskeletal injuries
- period pain
It can also be used in children from 2 years of age and
adolescents with rheumatoid arthritis.

2. What you need to know before you take
Naproxen
Do not take Naproxen:
• if you are allergic to naproxen or any of the other
ingredients of this medicine (listed in section 6).
• if you have a history of asthma attacks, angioedema,
skin reactions or acute rhinitis after taking
acetylsalicylic acid or any other NSAIDs.
• if you have blood formation disturbances.
• if you have now an ulcer or bleeding in your stomach
or gut.
• If you have a history of recurrent stomach/duodenal
ulcers (peptic ulcers) or bleeding (at least two different
episodes of confirmed ulcers or bleeding).
• if you have previously experienced bleeding or
perforation in your stomach or gut while taking
NSAIDs.
• if you have severe kidney, liver or heart failure.
• if you have a brain bleed.
• if you currently have any other form of acute bleeding.
• if you are in the last three months of pregnancy (see
“Pregnancy, breast-feeding and fertility”).
Warnings and precautions
Undesirable effects may be minimised by using the
lowest effective dose for the shortest duration necessary
to control the symptoms.
Medicines such as Naproxen may be associated with
a small increased risk of heart attack (“myocardial
infarction”) or stroke. Any risk is more likely with high
doses and prolonged treatment. Do not exceed the
recommended dose or duration of treatment.
If you have heart problems, have ever had a stroke
or think that you may be at increased risk for these
conditions (e.g.: high blood pressure, diabetes, elevated

cholesterol levels, or if you smoke), discuss this
treatment with your doctor or pharmacist.
Talk to your doctor or pharmacist before taking
Naproxen:
• if you have asthma, allergies (like hayfever) or chronic
obstructive airway disease or have had swelling of the
face, lips, eyes or tongue in the past.
• if you have lumps in your nose (polyps) or you sneeze
a lot or have a runny, blocked, or itchy nose (rhinitis).
• if you have a feeling of weakness (perhaps because
of an illness) or you are an older person.
• if you have problems with your kidneys or liver.
• if you have problems with the way that your blood
clots.
• if you are taking medicines such as corticosteroids,
anticoagulants, selective serotonin re-uptake
inhibitors (SSRIs), acetylsalicylic acid or NSAIDs
including COX-2 inhibitors.
• if you have previously experienced stomach ulcer
or bleeding. You will be asked to report any unusual
symptoms from your stomach to your doctor.
• if you have an autoimmune condition, such as
‘systemic lupus erythematosus’ (SLE, causes joint
pain, skin rashes and fever) or mixed connective
tissue disease and ulcerative colitis or Crohn’s
disease (conditions causing inflammation of the
bowel, bowel pain, diarrhoea, vomiting and weight
loss).
• if you have problems with vision or hearing.
• if you have had a major surgery shortly before starting
treatment with Naproxen.
• if you have heavy menstrual bleeding.
• if you have a disorder of the biosynthesis of the red
pigment that gives blood its colour (porphyria).
This medicine must be stopped immediately in case
of gastrointestinal bleeding or visual disturbances or
hearing impairment.
There have been very rarely reports of severe skin
reactions (including exfoliative dermatitis, StevensJohnson syndrome or toxic epidermal necrolysis)
associated with the administration of NSAIDs. These

reactions usually occur at the start of treatment (in
the first month). If you develop a skin rash (including
lesions of the mucous membranes such as mouth,
throat, nose, eyes, genitals) or any other signs of
hypersensitivity, stop using Naproxen and contact your
doctor immediately.
General information
Pain relief and underlying illness
If, during treatment with naproxen, you do not feel better,
or if you should continue to have pain, fever, fatigue or
other signs of illness, please ask your doctor for advice.
This is because painkillers may mask possible warning
signs of an underlying illness.
Headache from painkillers
Prolonged, high-dose use of painkillers may cause
headaches that must not be treated by taking more
painkillers.
Kidney damage from painkillers
Habitual use of certain painkillers for a prolonged period
of time may lead to permanent kidney damage with the
risk of kidney failure.
If any of the above applies to you, or if you are not
sure, talk to your doctor or pharmacist before you
take Naproxen.
Laboratory test results
If your doctor recommends monitoring of your blood
counts, blood clotting and/or liver and kidney function
and/or any other tests (e.g. determination of the blood
levels of certain medicines), it is essential that you
have these tests performed. This applies particularly to
patients with impaired liver function, heart failure, high
blood pressure or kidney damage.
If you need to have an adrenal function test done, you
must (temporarily) stop taking Naproxen at least 3 days
before the test to avoid interference with the test result.
Children and adolescents
Naproxen is not recommended for use in children
under 2 years of age because there is no adequate
experience.
Naproxen is not recommended for use in any disorder
other than juvenile rheumatoid arthritis in children and
adolescents under 18 years of age.

Other medicines and Naproxen
Tell your doctor or pharmacist if you are taking, have
recently taken or might take any other medicines. This
includes medicines that you buy without a prescription
and herbal medicines. In particular, tell your doctor or
pharmacist if you are taking:
• Other NSAIDs including salicylates (like acetylsalicylic
acid) and COX-2 inhibitors
• Glucocorticoids (for swelling and inflammation), like
hydrocortisone, prednisolone and dexamethasone
• Medicine to stop your blood clotting, like warfarin,
heparin or clopidogrel
• Phenytoin (used to treat epilepsy)
• Sulfonamide medicines, like hydrochlorothiazide,
acetazolamide, indapamide and including
sulphonamide antibiotics (for infections)
• Oral medicines for the treatment of diabetes like
glimepiride or glipizide
• An ‘ACE inhibitor’ or any other medicine for high blood
pressure like cilazapril, enalapril or propranolol
• An angiotensin-II receptor antagonist, like
candesartan, eprosartan or losartan
• A diuretic (water tablet) (for high blood pressure), like
furosemide or triamterene
• A ‘cardiac glycoside’ (for heart problems), like digoxin
• A ‘quinolone antibiotic’ (for infections), like
ciprofloxacin or moxifloxacin
• Certain medicines for mental health problems like
lithium or selective serotonin reuptake inhibitors
(SSRIs) like fluoxetine or citalopram
• Probenecid and sulphinpyrazone (for gout)
• Methotrexate (used to treat skin problems, arthritis or
cancer)
• Ciclosporin or tacrolimus (for skin problems or after
an organ transplant)
• Zidovudine (used to treat AIDS and HIV infections)
• Mifepristone (used to end pregnancy or to bring on
labour if the baby has died)
• ‘Antacids’ (neutralise excess acid in the stomach)
If any of the above apply to you, or if you are not sure,

talk to your doctor or pharmacist before you take
Naproxen.
Naproxen with food, drink and alcohol
The consumption of alcoholic drinks during treatment
with Naproxen increases the risk of bleeding in the
gastrointestinal tract (stomach/intestine) and should
therefore be avoided.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be
pregnant or are planning to have a baby, ask your doctor
for advice before taking this medicine.
Pregnancy
During the first 6 months of pregnancy, the use of
Naproxen should be avoided unless explicitly instructed
by a doctor.
Do not take Naproxen if you are in the last 3 months of
pregnancy because it may harm you or your baby.
Do not take Naproxen after childbirth because it may
delay the process of the uterus shrinking back into its
normal shape and size.
Breast-feeding
You should avoid taking Naproxen if you are breastfeeding since it may pass into human milk in small
amounts.
Fertility
Naproxen may make it more difficult to become
pregnant. You should inform your doctor if you are
planning to become pregnant or if you have problems
becoming pregnant.
Driving and using machines
Naproxen may make you tired, dizzy, have problems
with your eyesight or other central nervous disturbances
may occur. Talk to your doctor if any of these happen to
you and do not drive or use any tools or machines.
Naproxen Oral Suspension contains sucrose,
sorbitol, sodium and methyl-parahydroxybenzoate
Sucrose
One mL of Naproxen Oral Suspension contains 300mg
sugar (sucrose) which corresponds to a bread exchange
of approximately 0.03. This should be taken into account
in patients with diabetes mellitus. If you have been told
by your doctor that you have an intolerance to some
sugars, contact your doctor before taking this medicinal

product.
May be harmful to the teeth.
Sorbitol
One mL of Naproxen Oral Suspension contains 128.6mg
sorbitol 70% solution – which is broken down in the body
to fructose (fruit sugar). If you have been told by your
doctor that you have an intolerance to some sugars,
contact your doctor before taking this medicinal product.
Sodium
This medicinal product contains 0.4mmol (or 9.2mg)
sodium per mL. To be taken into consideration by
patients on a controlled sodium diet.
Methyl-parahydroxybenzoate
This medicinal product contains methylparahydroxybenzoate as preservative. May cause
allergic reactions (possibly delayed).

3. How to take Naproxen
Always take this medicine exactly as your doctor has
told you. Check with your doctor or pharmacist if you are
not sure.
Shake the bottle vigorously before use. Take Naproxen
Oral Suspension with a sufficient amount of liquid.
Naproxen starts to act earlier when taken on an empty
stomach. Patients with sensitive stomach are advised to
take Naproxen Oral Suspension during meals.
Naproxen – like all NSAIDs – should be taken at the
lowest dose necessary for pain relief for the shortest
possible period of time. This precaution helps minimise
possible side effects.
The pack contains a 8mL graduated oral syringe
with graduations of 0.1mL which should be used to
administer this medicine.
Using the oral syringe:
• Immerse the tip of the oral syringe in the medicine.
• Whilst holding the syringe in place, gently pull the
plunger up drawing the medicine to the correct mark
on the syringe.
• When bubbles occur, release the medicine back
into the bottle and pull up the medicine again to the
correct mark on the syringe.
• Remove the syringe from the bottle.

• Place the end of the syringe in the patient’s mouth
and gently press the plunger down to slowly and
gently release the medicine.
• After use replace the bottle cap. Wash the syringe
with water. Disassemble the two parts of the syringe
and allow to dry. Store out of the reach of children.
Unless otherwise prescribed by your doctor, the
recommended dose is:
Adults up to 65 years of age
The recommended dose range is 10–20mL of Naproxen
Oral Suspension (500mg to 1,000mg naproxen) per day.
A daily dose of 20mL of Naproxen Oral Suspension
(1,000mg naproxen) should not be exceeded.
Dosage should be individually adjusted to the clinical
condition.
Symptomatic treatment of painful swelling or
inflammation after musculoskeletal injuries
The usual initial dose is 10mL of Naproxen Oral
Suspension (500mg naproxen). If necessary, you can
take an additional dose of 5mL (250mg naproxen) every
6 to 8 hours. The daily dose should not exceed 20mL of
Naproxen Oral Suspension (1,000mg naproxen).
Symptomatic treatment of pain and inflammation in
rheumatoid arthritis, ankylosing spondylitis and acute
attacks of osteoarthrosis and spondylarthrosis as well as
in inflammatory rheumatic diseases of soft tissues
The daily dose is usually 10–15mL of Naproxen Oral
Suspension (500–750mg naproxen). At the start of
therapy, during phases of acute inflammation or when
switching from another high-dose NSAID to Naproxen
Oral Suspension, the recommended dose is 15mL of
Naproxen Oral Suspension (750mg naproxen), taken
as two divided doses per day (10mL of Naproxen Oral
Suspension in the morning and 5mL in the evening, or
vice versa) or as a single dose (either in the morning or
in the evening).
In individual cases, your doctor can increase the daily dose
to 20mL of Naproxen Oral Suspension (1,000mg naproxen).
The maintenance dose is 10mL of Naproxen Oral
Suspension (500mg naproxen) per day, which may be
taken either in two divided doses (5mL in the morning
and 5mL in the evening) or as a single dose (either in
the morning or in the evening).

25803001

26.07.2016 12:25:24

Symptomatic treatment of pain and inflammation in
acute gout
The usual initial dose is 15mL of Naproxen Oral
Suspension (750mg naproxen); thereafter, take 5mL of
Naproxen Oral Suspension (250mg naproxen) every
8 hours until the attack is over. During acute gout
attacks, you may thus exceed the maximum daily dose
of 20mL (1,000mg naproxen) (for a short period of time).
Symptomatic treatment of period pain
The usual initial dose is 10mL of Naproxen Oral
Suspension (500mg naproxen); thereafter, you may take
5mL of Naproxen Oral Suspension (250mg naproxen)
every 6–8 hours. A daily dose of 20mL of Naproxen
Oral Suspension (1,000mg naproxen) should not be
exceeded.
Children from 2 years of age and adolescents for
the treatment of rheumatoid arthritis
The recommended dose is 10mg naproxen/kg body
weight per day which corresponds to a daily dose of
0.2mL of Naproxen Oral Suspension per kilogram
of body weight, administered in two divided doses
(single dose 0.1mL of Naproxen Oral Suspension (5mg
naproxen) per kilogram body weight). The daily dose
for adolescents should not exceed 20mL (1,000mg
naproxen).
Naproxen is not recommended for use in children under
2 years of age (see section “warnings and precautions”,
subsection “children and adolescents”).
Special patient populations
Elderly (over 65 years of age)
Careful monitoring by your doctor is necessary. In older
patients it is particularly important to select the lowest
effective dose of Naproxen for the shortest possible
duration (see section 2 “What you need to know before
you take Naproxen”).
Patients with impaired liver function
Patients with impaired liver function are at risk of overdose when taking Naproxen. Therefore, the lowest dose
of Naproxen that is still effective should be selected.
Careful monitoring by your doctor is necessary.
Should your liver function be severely impaired, you
must not take Naproxen (see section 2 “What you need
to know before you take Naproxen”).

1540100411G02.indd 2

Patients with impaired kidney function
Should your kidney function be impaired, your doctor
may want to reduce your Naproxen dose.
Should your kidney function be severely impaired, you
must not take Naproxen (see section 2 “What you need
to know before you take Naproxen”).
Duration of treatment
The duration of use is decided by the treating physician.
For rheumatic diseases, it may be necessary to take
Naproxen over a prolonged period.
In period pain the treatment duration depends on the
respective symptomology. However, the treatment with
Naproxen should not exceed a few days.
If you take more Naproxen than you should
If you take more Naproxen than you should, talk to
a doctor or go to a hospital straight away. Take the
medicine pack with you.

For healthcare professionals: Information on how
to manage poisoning with naproxen can be found at
the end of this package leaflet.
If you forget to take Naproxen
Do not take a double dose to make up for a forgotten
dose. Continue taking Naproxen as usual.
If you have any further questions on the use of this
medicine, ask your doctor or pharmacist.

4. Possible side effects
Like all medicines, this medicine can cause side effects,
although not everybody gets them. Medicines such as
Naproxen may be associated with a small increased risk
of heart attack (‘myocardial infarction’) or stroke.
Important side effects to look out for:
If you experience any of the following symptoms or
combinations of symptoms, please stop taking this
medicine and contact a doctor straight away. You
may need urgent medical treatment:
Severe allergic reactions (may affect up to 1 in 10,000
people), signs include:
• Shortness of breath
• Large drop in blood pressure
• Swelling of the face or throat, difficulty swallowing

• (Itchy) skin rash, redness, small blisters
Serious stomach and gut problems (may affect up to
1 in 10 people), signs include:
• Relatively severe abdominal (stomach) pain especially if onset is sudden
• Bloody vomit or coffee grounds-like vomit
• Bloody or black stools
• Ulcers, perforations (holes) and bleeds in your
stomach or gut sometimes fatal particularly in elderly
Heart attack, signs include:
• Chest pain which may spread to your neck and
shoulders and down your left arm
Liver problems (may affect up to 1 in 10,000 people),
signs include:
• Severe fatigue with loss of appetite, with or without
yellow colouration of the skin and the whites of the
eyes
• Feeling or being sick, or pale coloured stools
Impairment of sensory organs, e.g.:
• Suddenly occurring visual disturbances (may affect
up to 1 in 10,000 people) or hearing impairment (may
affect up to 1 in 10 people)
Aseptic meningitis (may affect up to 1 in 10,000
people), signs include:
• Severe headache - especially if onset is sudden
• Stiff neck, fever, feeling or being sick
• Confusion, sensitivity to bright light
Patients with autoimmune diseases (SLE, mixed
connective tissue diseases) are at increased risk for
developing meningitis.
Blood and lymphatic disorders (may affect up to 1 in
10,000 people), signs include:
• Flu-like symptoms, mouth sores, sore throat and
nosebleeds
Naproxen may cause the following side effects:
Very common side effects (may affect more than 1
in 10 people):
• Feeling sick
• Being sick
• Heartburn
• Stomach pain

• Fullness
• Constipation or diarrhoea and minor blood loss in the
gastrointestinal tract which, in exceptional cases, may
cause anaemia
Common side effects (may affect up to 1 in 10
people):
• Bleeding of the skin and mucous membranes
• Depression
• Dream abnormalities
• Difficulty falling asleep or staying asleep (insomnia)
• Headache
• Dizziness
• Agitation
• Irritability
• Sleep disturbances
• Tiredness
• Perception disorders and cognitive dysfunction
• Ringing noises in the ears
• Vertigo (dizziness)
• Sweating
• Fluid deposits in the body (oedema), especially in
patients with high blood pressure
• Thirst
Uncommon side effects (may affect up to 1 in 100
people):
• Blood count changes
• Increased counts of certain types of white blood cells
(eosinophilia)
• Asthma attacks (with and without drop in blood
pressure)
• Inflammation of the lungs (eosinophilic pneumonia)
• Symptoms in the lower abdomen (e.g. inflammation of
the large bowel with bleeding or worsening of Crohn‘s
disease/ulcerative colitis)
• Inflammation of the lining of the oral cavity (mouth)
• Injury to the food pipe
• Changes in liver function with transaminase elevation
• Hair loss (usually temporary)

• Inflammation of the skin caused by (sun)light (which
may include blistering)
• Muscle pain
• Muscle weakness
• Acute kidney failure
• Impairment of kidney function (nephrotic syndrome)
• Inflammation of the kidney(s) (interstitial nephritis)
• Fever and chills, malaise
• Inflammation of the stomach lining
• Gas
Rare side effects (may affect up to 1 in 1,000
people):
• Blistering skin conditions (epidermolysis bullosa-like
reactions)
Very rare side effects (may affect up to 1 in 10,000
people):
• Decreased red and/or white blood cell and/or blood
platelet counts (aplastic or haemolytic anaemia,
thrombocytopenia, leukopenia, pancytopenia,
agranulocytosis).
• Seizures (fits)
• Nerve inflammation
• High blood pressure
• Acceleration of the heart rate
• Pounding heart
• Heart failure
• Inflammation of blood vessels
• Worsening of infection-related inflammation (e.g.
development of necrotising fasciitis, i.e. acute
inflammation and necrosis [death of tissue] of the fatty
tissue beneath the skin and muscles).
• Anaphylactic or anaphylactoid systemic reactions
• Liver inflammation (hepatitis), liver damage especially
after long-term therapy
• Hypersensitivity reactions such as skin rash,
erythema multiforme, in isolated cases manifesting
as severe cutaneous adverse reactions (including
Stevens-Johnson syndrome or toxic epidermal
necrolysis)

• Kidney damage (renal papillary necrosis) (especially
during long-term therapy)
• Increased uric acid level in the blood
Not known (frequency cannot be estimated from the
available data):
• Increased potassium levels
• Decreased white blood cell counts (neutropenia).
• Swelling of the lens and optic nerve head
• Corneal opacity
• Inflammation of the optic nerve head
• Pins and needles or numbness of your hands and feet
• Lung oedema
• Inflammation of the pancreas (a large gland behind
the stomach)
• Erythema nodosum (a skin inflammation that involves
reddish painful bumps)
• Lichen planus (a non-infectious, itchy rash that can
affect many areas of the body)
• Systemic lupus erythematosus (SLE, an autoimmune
condition leading to an inflammatory process that can
affect various parts of the body)
• Pustular reaction
• Blood in the urine (haematuria)
• Inflammation of certain parts of the kidneys
(glomerulonephritis)
• Female infertility
• Oedema
Naproxen may interfere with laboratory test results; you
should therefore inform all of your doctors (if applicable)
that you are taking Naproxen (see section 2 “What you
need to know before you take Naproxen”).
Methyl-parahydroxybenzoate may cause hypersensitivity
reactions, including delayed reactions.
Side effects in children and adolescents
The frequency, type and severity of side effects in
children and adolescents are similar to those in adults.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this
leaflet. You can also report side effects directly via the

Yellow Card scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more
information on the safety of this medicine.

5. How to store Naproxen
Store in the original package in order to protect from
light.
After first opening, this medicine is stable for 3 months.
Store in the original package in order to protect from
light.
Keep this medicine out of the sight and reach of
children.
Do not use this medicine after the expiry date which is
stated on the label and on the carton after “EXP”. The
expiry date refers to the last day of that month.
Do not throw away any medicines via waste-water.
Ask your pharmacist how to throw away medicines you
no longer use. These measures will help protect the
environment.

6. Contents of the pack and other information
What Naproxen Oral Suspension contains
• The active substance is: naproxen
1mL of Naproxen Oral Suspension contains 50mg
naproxen.
• The other ingredients are: sucrose (sugar), saccharin
sodium (E 954), sodium cyclamate (E 952), sodium
chloride, methyl-parahydroxybenzoate (E 218),
potassium sorbate (E 202), tragacanth (E 413), citric
acid (E 330), sorbitol 70 % solution (E 420), water,
orange flavour, pineapple flavour.
What Naproxen Oral Suspension looks like and
contents of the pack
Naproxen Oral Suspension is a white to yellowish-white
oral suspension with orange and pineapple flavour.
Amber glass bottle with child-resistant screw closure
8mL graduated oral syringe with graduations of 0.1mL
Pack size: 100mL

Marketing Authorisation Holder and Manufacturer
Infectopharm Arzneimittel und Consilium GmbH
Von-Humboldt-Str. 1
64646 Heppenheim
Germany
Distributed by:
Thornton & Ross Ltd., Linthwaite, Huddersfield,
HD7 5QH, United Kingdom
This leaflet was last revised in June 2016

The following information is intended for healthcare
professionals only:
In case of a naproxen overdose:
Symptoms of overdose
Symptoms of overdose may include CNS disturbances
including headache, dizziness or lightheadedness, and
epigastric pain and abdominal discomfort, indigestion,
nausea, vomiting, transient change in hepatic function,
hypoprothrombinaemia, renal dysfunction, metabolic
acidosis, apnoea and disorientation. Naproxen can be
absorbed rapidly. High and early drug concentrations
in the blood should be expected. A few patients have
experienced seizures, but it remained unclear whether
these were caused by treatment with naproxen.
Gastrointestinal bleeding may also occur. Hypertension,
acute renal failure, respiratory depression and coma
may occur, but are rare. Anaphylactic reactions have
been described after treatment with non-steroidal
anti-inflammatory drugs and may also occur following
overdose.
Management of overdose
Patients should be treated symptomatically. There is
no specific antidote. Preventive measures to avoid
further absorption (e.g. administration of activated
charcoal) may be indicated in patients within four
hours after ingestion or because of a large overdose.
Forced diuresis, alkalinisation of urine, haemodialysis or
haemoperfusion are probably unsuitable because of the
high protein binding of naproxen.
25803001
1540100411G02

26.07.2016 12:25:24

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide